Bioinvenu Illuminating Drug Targets

Skip to primary content. Skip to secondary content. GPCR14-3-3 Signaling Pathway Assays. GPCRß-arrestin Signaling Pathway Assays. Cell-based Kinase Signaling Pathway Assays. RTK Signaling pathway Assays. NHR Signaling Pathway Assays. GPCR14-3-3 Signaling Pathway LinkLight Assay Cells. GPCRß-arrestin Signaling Pathway LinkLight Assay Cells. Kinase Signaling Pathway LinkLight Assay Cells. Custom Protein-protein LinkLight Development. Quotations Ordering. Mission and About Us. BioInvenu has the exc.

OVERVIEW

This domain bioinvenu.com presently has an average traffic ranking of zero (the lower the superior). There is one contacts and addresses for bioinvenu.com to help you communicate with them. This domain bioinvenu.com has been online for seven hundred and ninety-four weeks, nineteen days, two hours, and seven minutes.
Contacts
1
Locations
1
Online Since
Apr 2010

BIOINVENU.COM RANKINGS

This domain bioinvenu.com is seeing varying quantities of traffic all through the year.
Traffic for bioinvenu.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for bioinvenu.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for bioinvenu.com

Date Range

All time
This Year
Last Year
Last Month

BIOINVENU.COM HISTORY

This domain bioinvenu.com was first submitted to the registrar on April 25, 2010. It was updated on April 18, 2014. This website will go back on the market on April 24, 2015. It is currently seven hundred and ninety-four weeks, nineteen days, two hours, and seven minutes young.
REGISTERED
April
2010
UPDATED
April
2014
EXPIRED
April
2015

LENGTH OF LIFE

15
YEARS
2
MONTHS
18
DAYS

LINKS TO WEB SITE

WHAT DOES BIOINVENU.COM LOOK LIKE?

Desktop Screenshot of bioinvenu.com Mobile Screenshot of bioinvenu.com Tablet Screenshot of bioinvenu.com

CONTACTS

Privacy Protection Service INC dba PrivacyProtect.org

Domain Admin

C/O ID#10760, PO Box 16 Note - Visit PrivacyProtect.org to contact the domain owner/operator Note - Visit PrivacyProtect.org to contact the domain owner/operator

Nobby Beach, Queensland, QLD 4218

AU

BIOINVENU.COM HOST

I found that a lone page on bioinvenu.com took seven hundred and eighteen milliseconds to load. I could not observe a SSL certificate, so in conclusion we consider bioinvenu.com not secure.
Load time
0.718 secs
SSL
NOT SECURE
Internet Protocol
198.252.98.30

NAME SERVERS

ns1.hawkhost.com
ns2.hawkhost.com

WEBSITE IMAGE

SERVER OS

I observed that bioinvenu.com is employing the LiteSpeed server.

PAGE TITLE

Bioinvenu Illuminating Drug Targets

DESCRIPTION

Skip to primary content. Skip to secondary content. GPCR14-3-3 Signaling Pathway Assays. GPCRß-arrestin Signaling Pathway Assays. Cell-based Kinase Signaling Pathway Assays. RTK Signaling pathway Assays. NHR Signaling Pathway Assays. GPCR14-3-3 Signaling Pathway LinkLight Assay Cells. GPCRß-arrestin Signaling Pathway LinkLight Assay Cells. Kinase Signaling Pathway LinkLight Assay Cells. Custom Protein-protein LinkLight Development. Quotations Ordering. Mission and About Us. BioInvenu has the exc.

CONTENT

This domain states the following, "Cell-based Kinase Signaling Pathway Assays." We analyzed that the web site also said " GPCR14-3-3 Signaling Pathway LinkLight Assay Cells." It also stated " GPCRß-arrestin Signaling Pathway LinkLight Assay Cells. Kinase Signaling Pathway LinkLight Assay Cells."

VIEW OTHER BUSINESSES

b i o i n v e r s o r El rincón del inversor en biotecnología

El rincón del inversor en biotecnología. Dos fondos estadounidenses estarían preparando la entrada en Zeltia. Sube, sube, Zeltia. Sube, sube Zeltia! Enhorabuena a todos, especialmente a las pacientes que padecen un cancer de ovario. Es un día de gran alegría para todos.

Invertebrados

Conheça a Biodiversidade do nosso Planeta. Domingo, 1 de junho de 2008. O amensalismo ou antibiose consiste numa relação desarmônica em que indivíduos de uma população secretam substâncias que inibem ou impedem o desenvolvimento de indivíduos de populações de outras espécies. Sexta-feira, 23 de maio de 2008. Quinta-feira, 22 de maio de 2008. Jornais 2 a 6 semanas. Latas de alumínio 100 a 500 anos. Garrafa de vidro mais de 1000 anos.

BioInvest Publisher of the Medical Technology Stock Letter

Yahoo finance API is not available right now, please try again soon. Clearly BMS paid handsomely for what may have been the most attractive asset in the space. TAU The Next Target For Neurology Focus On IONS and SGMO. MDCO ORION Inclisiran Rising In The PCSK9 Sky. A Brief Look At Shorts.